Tuesday’s Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
from USATODAY - Nation Top Stories https://ift.tt/2XxLbb4
via IFTTT https://ift.tt/2Snb6OQ
Congress to square off against pharmaceutical CEOs in showdown over drug prices
![Congress to square off against pharmaceutical CEOs in showdown over drug prices]()
Reviewed by Unknown
on
February 26, 2019
Rating:
No comments: